Boehringer Ingelheim

It is the generic version of Pradaxa Capsules, 75 mg, 110 mg, and 150 mg, of Boehringer Ingelheim 

Transaction expands Boehringer Ingelheim’s R&D and clinical manufacturing capabilities with a site focused predominantly on…

The primary endpoint of the study is percent change in forced vital capacity, a measurement of lung function, compared to baseline…

Under the License Agreement, Bridge Biotherapeutics will regain all rights to BBT-877

They assured that they will work towards developing innovations to fight the COVID-19 pandemic, ensuring their timely availability…

Approximately 55 per cent of type T2D patients suffer from cardiovascular disease (CVD), which often leads to further…

Under the terms of the partnership agreement, Click Therapeutics will be primarily responsible for research and development…

The terms of the collaboration also include an option for Boehringer Ingelheim to negotiate an exclusive right to biomarkers…

Results from the Phase III EMPEROR-Reduced trial were published in The New England Journal of Medicine

The CARE consortium comprises 37 teams from academic and non-profit research institutions and pharma companies